EUVIMEDOpdag EUVIMED
EUVIMED · CrossrefJournal

Gynecologic Oncology

ISSN 0090-8258 · Elsevier BV

Latest articles

  1. Corrigendum to “Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980–2023) with focus on younger women (0–49 years old)”. [Gynecol. Oncol. 212 (2026) 152–159]

    Charlotta Riese, Enoch Yi-Tung Chen, Hanna Nilsson, Sahar Salehi, Anna Sara Oberg, Simon Mathis Kønig, Richard G. Feltbower, Christine Rousset-Jablonski, Magdalena Balcerek, Kenny Rodriguez-Wallberg

    Published: 2026-12DOI: 10.1016/j.ygyno.2026.10.017

  2. Novel orthotopic uterine leiomyosarcoma model demonstrated enhanced tumor growth, metastasis, and chemosensitivity compared to subcutaneous counterparts

    Megan E. Doherty, Minnie Malik, Yuka Otsuka, Hengying Ellery, Lisa Myers, Suzanne Jokajtys, Collin A. Sitler, Anthony DeAngelis, Alexandru Korotcov, Nicholas Pyskir, Nicholas W. Bateman, Thomas P. Conrads, Kathleen M. Darcy, G. Larry Maxwell, Christopher M. Tarney, Joy L. Britten, William H. Catherino

    Published: 2026-12DOI: 10.1016/j.ygyno.2026.10.023

  3. A phase I trial of intravenous vesicular stomatitis virus expressing thyroidal sodium iodide symporter (NIS) and human interferon beta (hIFNβ) in metastatic or recurrent endometrial cancer

    Simrit K. Warring, Kah-Whye Peng, Pamela J. Atherton, Erik J. Asmus, Lianwen Zhang, Courtney L. Erskine, Yi-ying Ma, Nandakumar Packiriswamy, Megan E. Grudem, Carolyn M. Klampe, Saravut J. Weroha, Aminah Jatoi, Andrea E. Wahner Hendrickson, Paula Gill, Gretchen E. Glaser, Amanika Kumar, Carrie L. Langstraat, Matthew S. Block, Jamie N. Bakkum-Gamez

    Published: 2026-12DOI: 10.1016/j.ygyno.2026.10.027

  4. Low-grade serous ovarian cancer: 2026 expert consensus report

    Rachel N. Grisham, Brian Slomovitz, Vivek Podder, Charlotte Sun, Nicole Andrews, Beryl Manning-Geist, Russell Vang, Lauren P. Cobb, Susana Banerjee, Charlie Gourley, Allireza Alloo, Amanda N. Fader, Jubilee Brown, Stéphanie Gaillard, Isabelle Ray-Coquard, David M. O'Malley, Heather E. Cunliffe, Shannon N. Westin, Dimitrios Nasioudis, Thomas J. Herzog, Kathleen N. Moore, Robert L. Coleman, Mark S. Carey, Anna DeFazio, Fiona Simpkins, Robert L. Hollis, Kwong-Kwok Wong, Dane Cheasley, Anil K. Sood, Jane Ludemann, Rosemary L. Balleine, Elsa Larsen, Alicia Didsbury, Emily Campbell, Michelle Flint, Jeffrey Girshman, Anais Malpica, Kathleen I. Pishas, David M. Gershenson

    Published: 2026-11DOI: 10.1016/j.ygyno.2026.10.011

  5. Four-year survival outcomes with dostarlimab plus chemotherapy in mismatch repair deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer in the RUBY trial

    Matthew A. Powell, Henrik Roed, Lyndsay J. Willmott, David Cibula, Destin Black, Giorgio Valabrega, Sudarshan Sharma, Stefan Kommoss, Lisa M. Landrum, Ingrid Boere, Cara Mathews, Vladyslav Sukhin, Michael A. Gold, Caroline Lundgren, Sarah E. Gill, Lucy Gilbert, Ilana Cass, Mitchell I. Edelson, Joseph Buscema, Nicole S. Nevadunsky, Kari Ring, Bhavana Pothuri, Helen D. Eshed, Carolyn McCourt, Robert L. Coleman, Matthew Grimshaw, Laura Austin, Magdalena Zajac, Brian Slomovitz, Trine Nøttrup

    Published: 2026-09DOI: 10.1016/j.ygyno.2026.05.008

  6. Integrated expression profiling of trophoblast cell-surface antigen 2 (TROP2), folate receptor alpha (FRα), and human epidermal growth factor receptor 2 (HER2) in endometrial Cancer across molecular classes, genomic alterations, and histologic subtypes

    Orazio De Tommasi, Luca Palmieri, Stefania Bellone, Natalia Buza, Namrata Sethi, Sarah Ottum, Cem Demirkiran, Pei Hui, Tong Sun, Na Niu, Victoria M. Ettorre, Tobias M.P. Hartwich, Roberto Tozzi, Alessandro D. Santin

    Published: 2026-09DOI: 10.1016/j.ygyno.2026.08.002

Volumes

2026 · 3372025 · 9302024 · 1,0452023 · 9082022 · 1,0522021 · 1,1082020 · 1,4712019 · 1,1802018 · 9642017 · 1,0262016 · 9972015 · 1,1452014 · 1,0952013 · 9982012 · 1,0372011 · 8672010 · 4562009 · 4722008 · 5132007 · 6512006 · 6072005 · 6932004 · 6632003 · 5112002 · 3732001 · 4292000 · 3821999 · 4231998 · 3161997 · 3881996 · 3471995 · 3421994 · 3571993 · 3221992 · 4501991 · 3371990 · 4421989 · 5081988 · 2431987 · 200

Viden, der passer til dit arbejde.

Fra en gratis start over personlig litteratursøgning til den komplette Research Suite.

Se priser →

Er alle forlagsfuldtekster inkluderet?

Nej. Bibliografiske referencer, abstracts og fuldtekster er forskellige typer indhold. Om en fuldtekst er tilgængelig, afhænger af kilden, Open Access og dine eksisterende licenser. Et EUVIMED-abonnement erstatter ikke yderligere forlagsrettigheder.